Dianthus Therapeutics DNTH
NASDAQ DNTH
$89.98 +1.93 (+2.19%)
As of: Oct 1, 2026 · 11:27 AM EDT

Dianthus Therapeutics (DNTH) Cash from Financing Activities (2017 - 2025)

Updated

Dianthus Therapeutics (DNTH) recorded Cash from Financing Activities of $274.51 million in Q3 2025, compared with $296,000 a year earlier.

Analysis

Dianthus Therapeutics (DNTH) Cash from Financing Activities (2017 - 2025) Analysis & Trends

On a TTM basis, Dianthus Therapeutics' Cash from Financing Activities came in at $314.92 million as of Sep 30, 2025, up 49.2% year-over-year; for FY2024, it was $255.62 million, up 91.4% from FY2023.

  • Annual Cash from Financing Activities has increased for five straight years, with a five-year compound annual growth rate of 32.6% (FY2019 to FY2024).
  • Across earlier years, Cash from Financing Activities came in at $133.57 million in FY2023 (+38.2%), $96.68 million in FY2022 (+7.9%), $89.6 million in FY2021 (+32.3%) and $67.74 million in FY2020 (+8.7%).
  • The Q3 2025 figure is the highest quarterly Cash from Financing Activities in data going back to Q3 2017.
  • Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 43.3% in Q3 2023, against a decline of 99.9% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $568,000 (Q2 2025), $161,000 (Q1 2025) and $39.68 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Dianthus Therapeutics 3.77 Bn 3.72 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 274.51 Mn
Jun 30, 2025 568,000.00
Mar 31, 2025 161,000.00
Dec 31, 2024 39.68 Mn
Sep 30, 2024 296,000.00
Jun 30, 2024 -2.20 Mn
Mar 31, 2024 217.85 Mn
Dec 31, 2023 -4.87 Mn
Sep 30, 2023 138.44 Mn
Sep 30, 2022 96.63 Mn
Jun 30, 2022 49,000.00
Dec 31, 2021 124,000.00
Sep 30, 2021 203,000.00
Jun 30, 2021 88.86 Mn
Mar 31, 2021 418,000.00
Dec 31, 2020 1.18 Mn
Sep 30, 2020 -159,000.00
Jun 30, 2020 65.60 Mn
Mar 31, 2020 1.12 Mn
Dec 31, 2019 914,000.00
API Access

Dianthus Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=DNTH&period=max&api_key=YOUR_API_KEY